INNOGEN-B
0259118AListed醫療健康 · 公司是一家专注于糖尿病及代谢疾病创新疗法研发、生产和商业化的生物制药企业。
High attention
77.8
/100
- Offer price
- HK$18.68
- Final offer price
- HK$18.68
- Lot / entry fee
- 200 shares · HK$4K
- Proceeds
- HK$682.9M
- Sponsor
- CITIC Securities / CICC
- Est. margin oversub.
- 4432.0x
- Public oversub.
- 5341.7x
- One-lot win rate
- 0.5%
- First-day return
- +206.5%
Offer starts
Aug 7
Offer closes
Aug 12
Grey market
Aug 14
Listing
Aug 15
AI reference scoring and scenarios
After grey market
After grey market L1 heat score
77.8/ 100
Data coverage Mid-high
Target
Prior calibration
Listing-day trend
PositivePartial basis
Up probability
76.0%
First-day reference range
+254.7% – +338.2%
Published outcome check
First-day resultBig up+206.5%
Our call: Trend call valid
Covered 15/25 core factors
UsedMissingNot yet scorableN/A
Margin oversubscription
High heatOffer size
Good qualityCornerstone lockup
Low supportPost-lockup offer value
Medium scarcityRecent same-rule trend
—Recent same-type trend
—Recent sector trend
—Valuation
Weak appealFundamental quality
Average qualityGrowth quality
—Profitability
Weak qualityCash runway
Weak qualityCustomer concentration
—Cornerstone quality
Strong supportSponsor record
Strong recordGreenshoe arrangementGreenshoe: yes · 15%
Average supportStabilizer track record
—A-share pre-grey trend
—A-share listing-day trend
—Public oversubscription
High heatOne-lot win rate
High heatInternational placing
High heatFinal pricing position
—Actual greenshoe use
—Grey market return
Strong trendThe assessment and probability ranges are informational only and are not investment advice.
AI Research Report
After grey marketThe analysis report for this IPO is being generated.